Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Remission of T2DM requires early diagnosis and substantial weight reduction

Nature Reviews Endocrinology volume 18, pages 329–330 (2022)Cite this article

Subjects

Remission of type 2 diabetes mellitus is highly desirable and potentially reduces risks of complications. Improving the probability of remission requires early detection and substantial weight loss during a 6-year therapeutic window when β-cells remain functional.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Fang, M., Wang, D., Coresh, J. & Selvin, E. Trends in diabetes treatment and control in U.S. adults, 1999–2018. N. Engl. J. Med. 384, 2219–2228 (2021).

    Article  Google Scholar 

  2. Wang, L. et al. Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999–2018. J. Am. Med. Assoc. 326, 1–13 (2021).

    Google Scholar 

  3. Gregg, E. W., Hora, I. & Benoit, S. R. Resurgence in diabetes-related complications. J. Am. Med. Assoc. 321, 1867–1868 (2019).

    Article  Google Scholar 

  4. Lean, M. E. J. et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol. 7, 344–355 (2019).

    Article  Google Scholar 

  5. Taheri, S. et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 8, 477–489 (2020).

    Article  Google Scholar 

  6. Gregg, E. W. et al. Look AHEAD Research Group. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 4, 913–921 (2016).

    Article  Google Scholar 

  7. Sjöström, L. et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. J. Am. Med. Assoc. 311, 2297–2304 (2014).

    Article  Google Scholar 

  8. Fultang, J., Chinaka, U., Rankin, J., Bakhshi, A. & Ali, A. Preoperative bariatric surgery predictors of type 2 diabetes remission. J. Obes. Metab. Syndr. 30, 104–114 (2021).

    Article  Google Scholar 

  9. Lind, M., Imberg, H., Coleman, R. L., Nerman, O. & Holman, R. R. Historical HbA1c values may explain the type 2 diabetes legacy effect: UKPDS 88. Diabetes Care 44, 2231–2237 (2021).

    Article  CAS  Google Scholar 

  10. Riddle, M. C. et al. Consensus Report: definition and interpretation of remission in Type 2 diabetes. Diabetes Care 44, 2438–2444 (2021).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Professor José Luiz Medina passed away recently after a prolonged illness. He was Professor Emeritus at the Faculty of Medicine of the University of Porto. His scholarship, influence, commitment to young trainees in endocrinology, humanism and contribution to public health were renowned throughout Portugal. Professor Medina touched many lives and his memory will continue to inspire future generations.

Author information

Author notes

  1. Deceased: José Luiz Medina.

Authors and Affiliations

  1. Division of Endocrinology, Diabetes and Metabolism, New York University Grossman School of Medicine, New York, NY, USA

    Michael Bergman

  2. Department of Endocrinology and Diabetology, Université Catholique de Louvain, University Clinic Saint Luc, Brussels, Belgium

    Martin Buysschaert

  3. Faculty of Medicine, University of Porto, Porto, Portugal

    José Luiz Medina

  4. Public Health Promotion Unit, Finnish Institute for Health and Welfare, Helsinki, Finland

    Jaakko Tuomilehto

  5. Department of Public Health, University of Helsinki, Helsinki, Finland

    Jaakko Tuomilehto

  6. Saudi Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia

    Jaakko Tuomilehto

  7. Department of International Health, National School of Public Health, Instituto de Salud Carlos III, Madrid, Spain

    Jaakko Tuomilehto

Authors
  1. Michael Bergman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Buysschaert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. José Luiz Medina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jaakko Tuomilehto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Bergman.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bergman, M., Buysschaert, M., Medina, J.L. et al. Remission of T2DM requires early diagnosis and substantial weight reduction. Nat Rev Endocrinol 18, 329–330 (2022). https://doi.org/10.1038/s41574-022-00670-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41574-022-00670-x

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing